Hormonrezeptor-positives, HER2‑negatives metastasiertes Mammakarzinom in der Prämenopause: endokrin-basierte Kombinationstherapie ist effektiver als Chemotherapie

Translated title of the contribution: Hormone receptor positive, HER2 negative premenopausal metastatic breast cancer—endocrine-based combination treatment is more effective than chemotherapy

M. Banys-Paluchowski*

*Corresponding author for this work
Translated title of the contributionHormone receptor positive, HER2 negative premenopausal metastatic breast cancer—endocrine-based combination treatment is more effective than chemotherapy
Original languageGerman
JournalOnkologe
Volume26
Issue number3
Pages (from-to)289-291
Number of pages3
ISSN0947-8965
DOIs
Publication statusPublished - 01.03.2020

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)
  • Centers: University Cancer Center Schleswig-Holstein (UCCSH)

Cite this